Real-world experience with gene therapy in Duchenne muscular dystrophy center readiness and patients safety: report from Qatar
Muhammad Osman(Weill Cornell Medical College in Qatar), Tawfeg Ben‐Omran(Qatar Airways (Qatar)), CM Gleeson(Qatar Airways (Qatar)), Ikram U. Haque, Khalid Ibrahim, Nawal Al‐Hamad(Public Authority for Applied Education and Training)
Cited by 1
Related Papers
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
|Neuromuscular Disorders|2019|636
Exome Sequencing Links Corticospinal Motor Neuron Disease to Common Neurodegenerative Disorders
|Science|2014|548
Guidelines for the diagnosis and management of cystathionine beta‐synthase deficiency
|Journal of Inherited Metabolic Disease|2016|335